Policy Advocacy Archive

Resident Rights Advocacy Initiative
Lindsay Heckler, Esq., MPH Lindsay Heckler, Esq., MPH

Resident Rights Advocacy Initiative

We want to hear from the community who have had personal experiences with nursing homes. In connecting with our community at large, we will be able to sharpen the tools we provide to residents that promote self-advocacy.

Read More
NEW YORK STATE DEPT OF HEALTH MUST DO MORE TO ENSURE RESIDENT HEALTH & SAFETY
Policy News Lindsay Heckler, Esq., MPH Policy News Lindsay Heckler, Esq., MPH

NEW YORK STATE DEPT OF HEALTH MUST DO MORE TO ENSURE RESIDENT HEALTH & SAFETY

The Office of the Comptroller released an audit that found the NYS Department of Health (DOH) efforts and transparency were controlled by the prior Executive’s narrative, and often misled the public, including when it came to the number of nursing home resident deaths. The audit also found that DOH was unprepared to respond to infectious

Read More
Testimony: Impact of Covid-19 on Programs and Services for Older Adults and Caregivers in New York State
Policy Statements and Testimony Lindsay Heckler, Esq., MPH Policy Statements and Testimony Lindsay Heckler, Esq., MPH

Testimony: Impact of Covid-19 on Programs and Services for Older Adults and Caregivers in New York State

We focus our testimony on the New York State Long Term Care Ombudsman Program (LTCOP) and its importance to residents who live in long-term care settings, their caregivers, and others. While focused on older adults and persons with disabilities who live in nursing homes, adult care facilities, and family-type homes, as stated below, LTCOP is an essential component in the long-term services and supports system.

Read More
The Misuse of Antipsychotics in Nursing Homes Must Stop
Policy News Lindsay Heckler, Esq., MPH Policy News Lindsay Heckler, Esq., MPH

The Misuse of Antipsychotics in Nursing Homes Must Stop

The misuse of antipsychotics in nursing homes is a form of chemical restraint and is abuse. Yet, these drugs are given to residents, many of whom are living with dementia, even though these drugs have an FDA “black box” warning against the use of these drugs for those residents. These drugs are associated with a significant increase in death, when given to older adults with dementia, and greatly increase the risk of falls, strokes, and other adverse events.

Read More